DekaBank Deutsche Girozentrale reduced its holdings in  Maximus, Inc. (NYSE:MMS – Get Rating) by 71.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor  owned 89,513 shares of the health services provider’s stock after selling 218,717 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Maximus were worth $6,544,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Victory Capital Management Inc. increased its position in  Maximus by 8.8% during the third quarter. Victory Capital Management Inc. now owns 6,169,884 shares of the health services provider’s stock worth $357,050,000 after purchasing an additional 497,114 shares during the last quarter.  The Manufacturers Life Insurance Company increased its position in  Maximus by 127.4% during the first quarter. The Manufacturers Life Insurance Company now owns 225,371 shares of the health services provider’s stock worth $17,138,000 after purchasing an additional 126,257 shares during the last quarter.  Federated Hermes Inc. increased its position in  Maximus by 38.8% during the first quarter. Federated Hermes Inc. now owns 377,081 shares of the health services provider’s stock worth $28,261,000 after purchasing an additional 105,322 shares during the last quarter.  Goldman Sachs Group Inc. increased its position in  Maximus by 49.9% during the second quarter. Goldman Sachs Group Inc. now owns 271,090 shares of the health services provider’s stock worth $16,946,000 after purchasing an additional 90,271 shares during the last quarter.  Finally, Dimensional Fund Advisors LP increased its position in  Maximus by 9.2% during the third quarter. Dimensional Fund Advisors LP now owns 907,692 shares of the health services provider’s stock worth $52,528,000 after purchasing an additional 76,597 shares during the last quarter. 97.41% of the stock is owned by hedge funds and other institutional investors.

Shares of MMS opened at $82.77 on Wednesday. Maximus, Inc. has a 1-year low of $54.46 and a 1-year high of $85.25. The stock has a market cap of $5.03 billion, a PE ratio of 26.79 and a beta of 0.69. The firm has a 50-day simple moving average of $80.09 and a two-hundred day simple moving average of $71.78. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.68 and a quick ratio of 1.68.

Maximus (NYSE:MMS – Get Rating) last announced its quarterly earnings results on Wednesday, February 8th. The health services provider reported $0.94 earnings per share for the quarter, beating analysts’ consensus estimates of $0.79 by $0.15. Maximus had a net margin of 4.03% and a return on equity of 16.64%. The business had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same period last year, the business earned $1.12 earnings per share. The business’s revenue for the quarter was up 8.5% on a year-over-year basis.  As a group, analysts forecast that  Maximus, Inc. will post 4.16 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 31st. Shareholders of record on Monday, May 15th will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date is Friday, May 12th. Maximus’s dividend payout ratio  is presently 36.25%.

Several research firms recently issued reports on MMS. Raymond James raised their price objective on shares of Maximus from $80.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, February 9th. StockNews.com began coverage on shares of Maximus in a research report on Thursday, March 16th. They set a “hold” rating for the company.

In related news, insider Ilene R. Baylinson sold 9,550 shares of Maximus stock in a transaction that occurred on Friday, February 10th. The shares were sold at an average price of $82.74, for a total value of $790,167.00. Following the completion of the transaction, the insider now owns 10,044 shares in the company, valued at $831,040.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own  1.30% of the company’s stock.

MAXIMUS, Inc engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U. S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Get Rating).

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.